IOVA
Iovance Biotherapeutics, Inc.Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-16 | WEISER MICHAEL |
Director |
Award↑
Filing footnotes — Deferred Restricted Stock Unit (Direct)
Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. |
Deferred Restricted Stock Unit
|
90,316 |
| 2026-06-16 | Puri Raj K. |
Chief Regulatory Officer |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. |
Restricted Stock Units
|
15,000 |
| 2026-06-16 | Maynard Ryan D |
Director |
Award↑
Filing footnotes — Deferred Restricted Stock Unit (Direct)
Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. |
Deferred Restricted Stock Unit
|
90,316 |
| 2026-06-16 | Dukes Iain D. |
Director |
Award↑
Filing footnotes — Deferred Restricted Stock Unit (Direct)
Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. |
Deferred Restricted Stock Unit
|
180,632 |
| 2026-06-16 | Countouriotis Athena |
Director |
Award↑
Filing footnotes — Deferred Restricted Stock Unit (Direct)
Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. |
Deferred Restricted Stock Unit
|
90,316 |
| 2026-06-05 | Vogt Frederick G |
Director, Interim CEO & General Counsel |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. |
Restricted Stock Units
|
15,625 |
| 2026-06-05 | BILINSKY IGOR |
Chief Operating Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. |
Restricted Stock Units
|
7,813 |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH |
Chief Medical Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. |
Restricted Stock Units
|
7,813 |
| 2026-06-05 | Puri Raj K. |
Chief Regulatory Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents the common stock remaining after deducting the common stock withheld for taxes. |
Common Stock
|
3,843 |
| 2026-06-05 | Puri Raj K. |
Chief Regulatory Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
Common Stock
|
9,766 |
| 2026-06-05 | Vogt Frederick G |
Director, Interim CEO & General Counsel |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents common stock remaining after deducting the common stock withheld for taxes. |
Common Stock
|
6,638 |
| 2026-06-05 | Puri Raj K. |
Chief Regulatory Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. |
Restricted Stock Units
|
9,766 |
| 2026-06-05 | BILINSKY IGOR |
Chief Operating Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
Common Stock
|
7,813 |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents the common stock remaining after deducting the common stock withheld for taxes. |
Common Stock
|
3,976 |
| 2026-06-05 | Vogt Frederick G |
Director, Interim CEO & General Counsel |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
Common Stock
|
15,625 |
| 2026-06-05 | BILINSKY IGOR |
Chief Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents common stock remaining after deducting the common stock withheld for taxes. |
Common Stock
|
3,976 |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH |
Chief Medical Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
Common Stock
|
7,813 |
| 2026-06-01 | Vogt Frederick G |
Director, Interim CEO & General Counsel |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
Common Stock
|
41,668 |
| 2026-06-01 | BILINSKY IGOR |
Chief Operating Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. |
Restricted Stock Units
|
8,790 |
| 2026-06-01 | GRAF FINCKENSTEIN FRIEDRICH |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents the common stock remaining after deducting the common stock withheld for taxes. |
Common Stock
|
4,473 |
| 2026-06-01 | Puri Raj K. |
Chief Regulatory Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. |
Restricted Stock Units
|
5,469 |
| 2026-06-01 | GRAF FINCKENSTEIN FRIEDRICH |
Chief Medical Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. |
Restricted Stock Units
|
8,790 |
| 2026-06-01 | Vogt Frederick G |
Director, Interim CEO & General Counsel |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents common stock remaining after deducting the common stock withheld for taxes. |
Common Stock
|
17,701 |
| 2026-06-01 | BILINSKY IGOR |
Chief Operating Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
Common Stock
|
8,790 |
| 2026-06-01 | Puri Raj K. |
Chief Regulatory Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
Common Stock
|
5,469 |
| 2026-06-01 | GRAF FINCKENSTEIN FRIEDRICH |
Chief Medical Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
Common Stock
|
8,790 |
| 2026-06-01 | Puri Raj K. |
Chief Regulatory Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents the common stock remaining after deducting the common stock withheld for taxes. |
Common Stock
|
2,508 |
| 2026-06-01 | BILINSKY IGOR |
Chief Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents common stock remaining after deducting the common stock withheld for taxes. |
Common Stock
|
4,473 |
| 2026-06-01 | Vogt Frederick G |
Director, Interim CEO & General Counsel |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. |
Restricted Stock Units
|
41,668 |
| 2026-05-11 | Kirby Daniel Gordon |
Chief Commercial Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
Common Stock
|
10,000 |
| 2026-05-11 | Kirby Daniel Gordon |
Chief Commercial Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on February 10, 2025, but does not include any other RSUs held by such Reporting Person. |
Restricted Stock Units
|
10,000 |
| 2026-05-11 | Kirby Daniel Gordon |
Chief Commercial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents the common stock remaining after deducting the common stock withheld for taxes. |
Common Stock
|
2,435 |
| 2026-03-09 | GRAF FINCKENSTEIN FRIEDRICH |
Chief Medical Officer |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. |
Restricted Stock Units
|
58,750 |
| 2026-03-09 | BILINSKY IGOR |
Chief Operating Officer |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. |
Restricted Stock Units
|
117,500 |
| 2026-03-09 | Kirby Daniel Gordon |
Chief Commercial Officer |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. |
Restricted Stock Units
|
132,200 |
| 2026-03-09 | Roche Corleen M. |
Chief Financial Officer |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. |
Restricted Stock Units
|
132,200 |
| 2026-03-09 | Vogt Frederick G |
Director, Interim CEO & General Counsel |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. |
Restricted Stock Units
|
235,000 |
| 2026-03-09 | Puri Raj K. |
Chief Regulatory Officer |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. |
Restricted Stock Units
|
117,500 |
| 2026-03-05 | Vogt Frederick G |
Director, Interim CEO & General Counsel |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents common stock remaining after deducting the common stock withheld for taxes. |
Common Stock
|
26,755 |
| 2026-03-05 | BILINSKY IGOR |
Chief Operating Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. |
Restricted Stock Units
|
31,246 |
| 2026-03-05 | Vogt Frederick G |
Director, Interim CEO & General Counsel |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. |
Restricted Stock Units
|
62,493 |
| 2026-03-05 | Vogt Frederick G |
Director, Interim CEO & General Counsel |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
Common Stock
|
62,493 |
| 2026-03-05 | Puri Raj K. |
Chief Regulatory Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
Common Stock
|
39,059 |
| 2026-03-05 | BILINSKY IGOR |
Chief Operating Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
Common Stock
|
31,246 |
| 2026-03-05 | GRAF FINCKENSTEIN FRIEDRICH |
Chief Medical Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
Common Stock
|
31,246 |
| 2026-03-05 | Puri Raj K. |
Chief Regulatory Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. |
Restricted Stock Units
|
39,059 |
| 2026-03-05 | GRAF FINCKENSTEIN FRIEDRICH |
Chief Medical Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. |
Restricted Stock Units
|
31,246 |
| 2026-03-05 | GRAF FINCKENSTEIN FRIEDRICH |
Chief Medical Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents the common stock remaining after deducting the common stock withheld for taxes. |
Common Stock
|
16,520 |
| 2026-03-05 | BILINSKY IGOR |
Chief Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents common stock remaining after deducting the common stock withheld for taxes. |
Common Stock
|
16,628 |
| 2026-03-05 | Puri Raj K. |
Chief Regulatory Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents the common stock remaining after deducting the common stock withheld for taxes. |
Common Stock
|
18,360 |